| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Cozzolino M et al. | Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT study. | 2014 | Nephrol. Dial. Transplant. | pmid:24500308 |
| Wang AY et al. | Effect of paricalcitol on left ventricular mass and function in CKD--the OPERA trial. | 2014 | J. Am. Soc. Nephrol. | pmid:24052631 |
| Sharma A et al. | Cost effectiveness of paricalcitol versus cinacalcet with low-dose vitamin D for management of secondary hyperparathyroidism in haemodialysis patients in the USA. | 2014 | Clin Drug Investig | pmid:24214232 |
| Donate-Correa J et al. | Selective vitamin D receptor activation as anti-inflammatory target in chronic kidney disease. | 2014 | Mediators Inflamm. | pmid:24511210 |
| Manucha W | [Mitochondria and oxidative stress participation in renal inflammatory process]. | 2014 | Medicina (B Aires) | pmid:24918679 |
| Sezer S et al. | Differential influence of vitamin D analogs on left ventricular mass index in maintenance hemodialysis patients. | 2014 | Int J Artif Organs | pmid:24619898 |
| Ellam T et al. | Vitamin D deficiency and exogenous vitamin D excess similarly increase diffuse atherosclerotic calcification in apolipoprotein E knockout mice. | 2014 | PLoS ONE | pmid:24586387 |
| GarcÃa IM et al. | Vitamin D receptor-modulated Hsp70/AT1 expression may protect the kidneys of SHRs at the structural and functional levels. | 2014 | Cell Stress Chaperones | pmid:24222043 |
| Freundlich M et al. | Paricalcitol downregulates myocardial renin-angiotensin and fibroblast growth factor expression and attenuates cardiac hypertrophy in uremic rats. | 2014 | Am. J. Hypertens. | pmid:24072555 |
| Gueutin V et al. | [Diabetic nephropathy: emerging treatments]. | 2014 | Nephrol. Ther. | pmid:24938412 |
Paricalcitol
Paricalcitol is a lipid of Sterol Lipids (ST) class. Paricalcitol is associated with abnormalities such as Vitamin D Deficiency. The involved functions are known as Hypertrophy, Left Ventricular. Paricalcitol often locates in Blood.
Cross Reference
Introduction
To understand associated biological information of Paricalcitol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Paricalcitol?
Paricalcitol is suspected in Vitamin D Deficiency and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with Paricalcitol
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Paricalcitol?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Paricalcitol?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Paricalcitol?
There are no associated biomedical information in the current reference collection.
What genes are associated with Paricalcitol?
There are no associated biomedical information in the current reference collection.
What common seen animal models are associated with Paricalcitol?
There are no associated biomedical information in the current reference collection.